| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/29/1993 | WO1993007874A1 Medicament composition for topical application |
| 04/29/1993 | WO1993007873A1 Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
| 04/29/1993 | WO1993007870A1 Device for the transdermal administration of melatonin |
| 04/29/1993 | WO1993007862A1 Ionic beads useful for controlled release and adsorption |
| 04/29/1993 | WO1993007861A1 Preparation and uses of multi-phase microspheres |
| 04/29/1993 | WO1993007860A1 New drug formulations with ion-exchangers |
| 04/29/1993 | WO1993007859A1 Novel pharmaceutical pellets and process for their production |
| 04/29/1993 | WO1993007858A1 Peroral drug delivery system |
| 04/29/1993 | WO1993007857A1 Stabilized calorific nutrient solution and multi-chamber system for the parenteral feeding of humans |
| 04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 04/29/1993 | WO1993007850A1 Methods of reducing plaque and gingivitis with reduced staining |
| 04/29/1993 | WO1993007842A1 Thermal enhancement of transdermal drug administration |
| 04/29/1993 | WO1993007840A1 Enzyme-orthokeratology |
| 04/29/1993 | WO1993007833A1 Biocompatible implant for the timing of ovulation in mares |
| 04/29/1993 | WO1993007747A1 Antimicrobial dialdehyde composition and methods of use |
| 04/29/1993 | DE4235312A1 Semi-solid mixts. of D- or L-lactic acid oligomer or polymer - used e.g. as resorbable implants, or bone waxes |
| 04/29/1993 | CA2122034A1 New drug formulations with ion-exchangers |
| 04/29/1993 | CA2121838A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | CA2121687A1 Ionic beads useful for controlled release and adsorption |
| 04/29/1993 | CA2121676A1 A stabilized caloric nutrient solution and a multicompartmental system or multiple recipient for human parenteral nourishing |
| 04/29/1993 | CA2120927A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 04/29/1993 | CA2120748A1 Peroral drug delivery system |
| 04/29/1993 | CA2116036A1 Device for the transdermal administration of melatonin |
| 04/28/1993 | EP0539319A2 Pharmaceutical cyclosporin composition |
| 04/28/1993 | EP0539304A1 Process to prepare orally absorbable extracts |
| 04/28/1993 | EP0539215A1 Penetration enhancement of topically applied formulations |
| 04/28/1993 | EP0539140A1 Lyophilized acidic fibroblast growth factor |
| 04/28/1993 | EP0539059A1 Buoyant controlled release powder formulation |
| 04/28/1993 | EP0538917A1 Vented wound dressing |
| 04/28/1993 | EP0538858A1 Improved lyophilized ifosfamide compositions |
| 04/28/1993 | EP0538486A1 Sewing machine needle and method of manufacturing same |
| 04/28/1993 | EP0538443A1 Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders. |
| 04/28/1993 | EP0538437A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| 04/28/1993 | EP0538433A1 Agent suitable for transdermal administration containing ergolin derivatives |
| 04/28/1993 | EP0538335A1 Dosage form for administering a drug to effect circadian therapy. |
| 04/28/1993 | EP0538313A1 Topical ophthalmic suspensions |
| 04/28/1993 | EP0533799A4 Compositions and methods for the controlled release of soluble active substances |
| 04/28/1993 | EP0527946A4 Controlled release vehicle |
| 04/28/1993 | EP0485530A4 Tgf--g(b) protein compositions for inhibition of cell proliferation |
| 04/28/1993 | EP0483213A4 Transdermal administration of lisuride |
| 04/28/1993 | EP0453525B1 Method of producing aqueous mixed-micelle solutions |
| 04/28/1993 | EP0386146B1 Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
| 04/28/1993 | EP0302097B1 Pharmaceutical compositions for treating obstructive air passage diseases |
| 04/28/1993 | EP0283513B1 Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |
| 04/28/1993 | CN1071334A Solid for mulation containing amide derivative and process for preparing same |
| 04/27/1993 | US5206347 Isolation and use of receptors binding to a peptide column |
| 04/27/1993 | US5206267 Suspension of butyl aminobenzoate; sterility; stability; nontoxic; polyethylene glycol suspending agent; wetting agent; for subcutaneous injection |
| 04/27/1993 | US5206220 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| 04/27/1993 | US5206219 Oral compositions of proteinaceous medicaments |
| 04/27/1993 | US5206156 Lactoperoxidase bonded to carrier of hydrophilic saccharide with lipid and phospholipid layers, oxygen donor, oxidizable substrate; food and medical uses |
| 04/27/1993 | US5206030 Blend of particles of water-soluble cellulose acetate, pigment particles, plasticizer, and surfactant |
| 04/27/1993 | US5206029 Separated enantiomorphs of flurbiprofen recombined in varying ratios, release agent |
| 04/27/1993 | US5206028 Dense collagen membrane matrices for medical uses |
| 04/27/1993 | US5206027 Amphipathic compound and liposome comprising the same |
| 04/27/1993 | US5206025 Inclusion compound of active substrance and cyclodextrin, and either diluent or binder |
| 04/27/1993 | US5206024 Density element for ruminal delivery device |
| 04/27/1993 | US5206023 Method and compositions for the treatment and repair of defects or lesions in cartilage |
| 04/27/1993 | US5206022 Insect repellent compositions |
| 04/27/1993 | US5206019 Soap compositions containing liquid-loaded powders |
| 04/27/1993 | US5206016 Cream containing aluminum potassium sulfate and process for preparing same |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | US5205290 Kits for imaging gastrointestinal disorders; anti-gas; biocompatible polymers, thickeners |
| 04/27/1993 | CA1316902C Lattice-entrapped composition |
| 04/27/1993 | CA1316829C Therapeutic composition containing sucrose fatty acid ester |
| 04/27/1993 | CA1316826C Binder-free granules with delayed release of the active compound |
| 04/27/1993 | CA1316825C Penetration enhancement systems |
| 04/27/1993 | CA1316824C Process for coating gelatin capsules |
| 04/27/1993 | CA1316823C Facilitation of certain drugs for capsulation |
| 04/27/1993 | CA1316820C Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
| 04/27/1993 | CA1316747C Chewing gum mineral supplement |
| 04/26/1993 | CA2081248A1 Novel saccharide-based matrix |
| 04/25/1993 | CA2080631A1 Process for preparing an active principle extract in dry absorbable forms and absorbable micro-granules obtained therewith |
| 04/24/1993 | CA2081061A1 Improved lyophilized ifosfamide compositions |
| 04/22/1993 | CA2080538A1 Lyophilized acidic fibroblast growth factor |
| 04/21/1993 | EP0538034A1 Taste mask coatings for preparing chewable pharmaceutical tablets |
| 04/21/1993 | EP0537998A1 Controlled release drug delivery device comprising a polymer matrix and a plasticizer |
| 04/21/1993 | EP0537729A1 Pharmaceutical compositions containing triazole derivatives for rectal administration |
| 04/21/1993 | EP0537559A1 Polymeric compositions useful as controlled release implants |
| 04/21/1993 | EP0537467A1 Microcapsules from isocyanates containing polyethylenoxid groups |
| 04/21/1993 | EP0537326A1 Rna delivery vector |
| 04/21/1993 | EP0537165A1 Polymeric drug delivery system |
| 04/21/1993 | EP0537139A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced. |
| 04/21/1993 | EP0504372A4 Cosmetic technology |
| 04/21/1993 | EP0407401B1 Human relaxin formulation |
| 04/21/1993 | EP0303683B1 Amphotericin b/cholesterol sulfate composition and method |
| 04/21/1993 | CN2130085Y Medical tampon |
| 04/21/1993 | CN1071076A Preparation of dual coptis Chinese aerosol |
| 04/20/1993 | US5204375 Betaine surface active agent having an estolide hydrophobic group |
| 04/20/1993 | US5204339 Penetration enhancers for transdermal delivery of systemic agents |
| 04/20/1993 | US5204335 Ifosfamide lyophilisate and process for its preparation |
| 04/20/1993 | US5204331 Composition for debridement of retained lens materials |
| 04/20/1993 | US5204121 Active material core, double layer comprising outer acrylic layer and inner jacket of hydrophobic additive and hydroxy-propyl cellulose |
| 04/20/1993 | US5204119 External preparation comprising calcium silicate |
| 04/20/1993 | US5204116 Dosage form providing immediate therapy followed by prolonged therapy |
| 04/20/1993 | US5204115 Granules with a non-cariogenic binder |
| 04/20/1993 | US5204114 Using crystalline ascorbic acid as an antistatic agent |
| 04/20/1993 | US5204113 Pharmaceutical compositions containing pentamidine |
| 04/20/1993 | US5204112 Induction of asymmetry in vesicles |
| 04/20/1993 | US5204111 Process for the preparation of alginate capsules, apparatus for producing said capsules and cosmetic compositions containing said capsules |
| 04/20/1993 | US5204109 Substrate with crosslinked (meth)acrylate gel, isosorbide dinitrate and compatible liquid; continuous migration to body |